chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left injection site arm) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination. No Medical History information was reported. On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced VACCINATION SITE PAIN (sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (sore left injection site arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Oct-2021, SARS-CoV-2 antibody test: equal to 189.0 Result: SARS-COV2 antibody level equal to 189.0 U/ml. On 22-Nov-2021, SARS-CoV-2 antibody test: greater than 2500 Result: SARS-COV2 antibody greater than 2500 U/ml. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.  No treatment information provided. This case was linked to MOD-2021-404656 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion/ Vaccinated after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion/ Vaccinated after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion/ Vaccinated after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.No concomitant medications were reported. It was reported that, the facility had 20 minutes of excursion in the freezer that their Moderna COVID-19 vials were stored in. The excursion was on Sunday and the health care profession was not told about it until the day of the repot. Later, the patient was vaccinated after excursion. No treatment information was reported.This case was linked to MOD-2021-403721 (Patient Link).Most recent FOLLOW-UP information incorporated above includes: On 03-Dec-2021: Follow-up information received includes patient details and vaccine details  were updated.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Aphonia, Dysphonia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Hoarse voice) and APHONIA (Lost his voice) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PREDNISONE for an unknown indication. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPHONIA (Hoarse voice) and APHONIA (Lost his voice). At the time of the report, DYSPHONIA (Hoarse voice) and APHONIA (Lost his voice) outcome was unknown. No treatment information was provided. The caller stated that it has nothing to do with Moderna vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Urticaria, Spinal stenosis, Thyroiditis NOS, Heartburn and Hives. Concurrent medical conditions included Cholesterol. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient Date of birth/age was reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: received a half dose booster vaccine (0.25ml) instead of a full third dose of 0.5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (received a half dose booster vaccine (0.25ml) instead of a full third dose of 0.5ml) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (received a half dose booster vaccine (0.25ml) instead of a full third dose of 0.5ml). On 23-Nov-2021, ACCIDENTAL UNDERDOSE (received a half dose booster vaccine (0.25ml) instead of a full third dose of 0.5ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not have information about the first 2 doses. Patient is on medication that can cause immunocompromise, and got cancer. No concomitant medication was reported. No treatment medication use was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Covid arm; pains, other pain; Headache; muscle aches; Fatigue; pain in the arm, in the area of the injection; fever of 99.8F°; chills; chest discomfort that  was not constant; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache) and MYALGIA (muscle aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027h21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 vaccination: Pfizer in March 2021 and Pfizer.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Dec-2021, the patient experienced CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches) and FATIGUE (Fatigue). At the time of the report, CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches), FATIGUE (Fatigue), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination complication, Vaccination site pain
Clinical narrative: Covid arm; pains, other pain; Headache; muscle aches; Fatigue; pain in the arm, in the area of the injection; fever of 99.8F°; chills; chest discomfort that  was not constant; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache) and MYALGIA (muscle aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027h21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 vaccination: Pfizer in March 2021 and Pfizer.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Dec-2021, the patient experienced CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches) and FATIGUE (Fatigue). At the time of the report, CHEST DISCOMFORT (chest discomfort that  was not constant), VACCINATION COMPLICATION (Covid arm), PAIN (pains, other pain), HEADACHE (Headache), MYALGIA (muscle aches), FATIGUE (Fatigue), VACCINATION SITE PAIN (pain in the arm, in the area of the injection), PYREXIA (fever of 99.8F°) and CHILLS (chills) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Mechanical urticaria, Pain, Pruritus, Urticaria
Clinical narrative: hives and reels; itches; painful; hot to touch; dermatological urticaria; urticaria; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives and reels), PRURITUS (itches), PAIN (painful), FEELING HOT (hot to touch) and MECHANICAL URTICARIA (dermatological urticaria) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 030M20A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives and reels), PRURITUS (itches), PAIN (painful), FEELING HOT (hot to touch), MECHANICAL URTICARIA (dermatological urticaria) and URTICARIA (urticaria). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA 12 HOUR) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives and reels), PRURITUS (itches), PAIN (painful), FEELING HOT (hot to touch), MECHANICAL URTICARIA (dermatological urticaria) and URTICARIA (urticaria) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Expired product administered, Product storage error
Clinical narrative: doses given after temperature excursion; Product storage error; 0.5 ml of booster dose dministered intramuscularly; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion), PRODUCT STORAGE ERROR (Product storage error) and ACCIDENTAL OVERDOSE (0.5 ml of booster dose dministered intramuscularly) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion), PRODUCT STORAGE ERROR (Product storage error) and ACCIDENTAL OVERDOSE (0.5 ml of booster dose dministered intramuscularly). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion), PRODUCT STORAGE ERROR (Product storage error) and ACCIDENTAL OVERDOSE (0.5 ml of booster dose dministered intramuscularly) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Product temperature excursion issue
Clinical narrative: Doses given after temperature excursion; Had a 20 min excursion in the freezer; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Had a 20 min excursion in the freezer) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Had a 20 min excursion in the freezer). On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (Doses given after temperature excursion). On 28-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Had a 20 min excursion in the freezer) had resolved. At the time of the report, PRODUCT ADMINISTRATION ERROR (Doses given after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not provided.  The dose was administered from 29-Nov-2021 to 01-Dec-2021.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Dec-2021: Follow up received contain patient demographics and dose details.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: doses given after temperature excursion; Product storage error; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) had resolved and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication was provided   This case was linked to MOD-2021-403721, MOD-2021-404754, MOD-2021-404793, MOD-2021-404629, MOD-2021-404644, MOD-2021-404804, MOD-2021-404757.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Product temperature excursion issue
Clinical narrative: This spontaneous case was reported by a respiratory therapist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer that their Moderna COVID-19 vials were stored in) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer that their Moderna COVID-19 vials were stored in). At the time of the report, PRODUCT ADMINISTRATION ERROR (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (20 minute excursion in the freezer that their Moderna COVID-19 vials were stored in) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product was provided by the reporter. No treatment medication was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product temperature excursion issue
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over her body and it is getting worse) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A, 004M20A and 026L20A) for COVID-19 vaccination. No medical history were provided by the reporter. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, the patient experienced URTICARIA (hives all over her body and it is getting worse). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency; HYDROXYZINE for Adverse event, at a dose of 25 milligram and FAMOTIDINE for Adverse event, at a dose of 40 milligram. At the time of the report, URTICARIA (hives all over her body and it is getting worse) had not resolved.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No medical history was reported. No concomitant medication was reported.  This case was linked to MOD-2021-404816, MOD-2021-404817 (Patient Link).
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (circular blotchy skin at the injection site) and VACCINATION SITE PAIN (is in a lot of pain,The pain comes from there) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21A, 001C21A and 016B212) for COVID-19 vaccination. Concomitant products included PANTOPRAZOLE, SIMVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CLOPIDOGREL, LEVOTHYROXINE SODIUM (LEVOTHYROXINE [LEVOTHYROXINE SODIUM]), LOSARTAN, METOPROLOL and PROBIOTICS NOS for an unknown indication. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced VACCINATION SITE PAIN (is in a lot of pain,The pain comes from there). On 04-Dec-2021, the patient experienced VACCINATION SITE DISCOLOURATION (circular blotchy skin at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (circular blotchy skin at the injection site) outcome was unknown and VACCINATION SITE PAIN (is in a lot of pain,The pain comes from there) had not resolved. The concomitant medications included unknown supplement.  No treatment was provided. No medical history was reported.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Gastrooesophageal reflux disease, Throat irritation
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux) and THROAT IRRITATION (burning in throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux) and THROAT IRRITATION (burning in throat). The patient was treated with ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Adverse event, at an unspecified dose and frequency and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux) and THROAT IRRITATION (burning in throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.No Concomitant informations were reported. This case was linked to MOD-2021-404762 (Patient Link).
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine) in an 8-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Date of First Dose: 12NOV2021 LOT# of First Dose: FK5127 (Pfizer) Expiration: Unknown Arm: Left Non Dominant) on 12-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An 8 year old was administered a booster dose of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided. Patient administered a second dose of unknown vaccine on 03DEC2021 on Left Non Dominant arm with unknown lot number and expiration.
Sex: U
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face is swollen) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Face is swollen). At the time of the report, SWELLING FACE (Face is swollen) outcome was unknown. No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (My arm was sore.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.  No Medical History information was reported.On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore.). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 15-Feb-2021 for Adverse event, at a dose of 2 tablet. At the time of the report, VACCINATION SITE PAIN (My arm was sore.) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications reported.This case was linked to MOD-2021-404784 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (a week after the 1st shot the entire arm was red and swollen, (upper half).) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE ERYTHEMA (a week after the 1st shot the entire arm was red and swollen, (upper half).). At the time of the report, VACCINATION SITE ERYTHEMA (a week after the 1st shot the entire arm was red and swollen, (upper half).) outcome was unknown.  mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No concomitant drugs was provided. No treatment drug information was provided by the reporter. This case was linked to MOD-2021-404816, MOD-2021-404738 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling, Rhinorrhoea, Sneezing
Clinical narrative: Runny nose/ sniffling nose; Swollen arm; Sneezing; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose/ sniffling nose), PERIPHERAL SWELLING (Swollen arm) and SNEEZING (Sneezing) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported. On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Nov-2021, the patient experienced RHINORRHOEA (Runny nose/ sniffling nose), PERIPHERAL SWELLING (Swollen arm) and SNEEZING (Sneezing). At the time of the report, RHINORRHOEA (Runny nose/ sniffling nose), PERIPHERAL SWELLING (Swollen arm) and SNEEZING (Sneezing) outcome was unknown.    No concomitant medications were provided. No treatment medications were reported. Reporter did not allow further contact.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Therapeutic response unexpected
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Expressed thanks to Moderna that her breathing has been easier) and HYPERSENSITIVITY (she just had some allergies growing up) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A, 010A21A and 07F21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Expressed thanks to Moderna that her breathing has been easier) and HYPERSENSITIVITY (she just had some allergies growing up). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Expressed thanks to Moderna that her breathing has been easier) had resolved and HYPERSENSITIVITY (she just had some allergies growing up) had not resolved. Concomitant medications were not reported. Treatment medications were not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received forst dose of JANSSEN COVID-19 VACCINE and second dose of Vaccine MRNA 1273 (Moderna)) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination. Previously administered products included for Prophylactic vaccination: JANSSEN COVID-19 VACCINE (Event Start Date : 12-Mar-2021;Event Stop Date : 15-Mar-2021;Duration : 3 D;Outcome: Recovered Causality: Possible; Action(s) taken with drug : Not Applicable) on 12-Mar-2021. Past adverse reactions to the above products included Tiredness with JANSSEN COVID-19 VACCINE. On 01-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received forst dose of JANSSEN COVID-19 VACCINE and second dose of Vaccine MRNA 1273 (Moderna)). On 01-Nov-2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received forst dose of JANSSEN COVID-19 VACCINE and second dose of Vaccine MRNA 1273 (Moderna)) had resolved. No concomitant medications reported. No Treatment medications reported. Patient reported no Adverse events after MRNA1273.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site reaction, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE ERYTHEMA (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE SWELLING (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE PRURITUS (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.) and VACCINATION SITE RASH (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE REACTION (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE ERYTHEMA (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE SWELLING (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE PRURITUS (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.) and VACCINATION SITE RASH (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE ERYTHEMA (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE SWELLING (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.), VACCINATION SITE PRURITUS (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.) and VACCINATION SITE RASH (With first dose, had COVID arm, red swollen, itchy and splotchy area on upper left arm.) had not resolved.    mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant medication was not provided.This case was linked to MOD-2021-404961 (Patient Link).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and HEADACHE (Headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported.On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced FATIGUE (Tired) and HEADACHE (Headache). In March 2021, FATIGUE (Tired) and HEADACHE (Headache) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.Patient was taking other medication. HCP was not aware of the side effects. No treatment information were provided. This case was linked to MOD-2021-404957, MOD-2021-404958 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenitis, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENITIS (swelling in left armpit lymph node), MYALGIA (I had body ache), NAUSEA (Nausea) and CHILLS (Chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A and 029L20A) for COVID-19 vaccination. No Medical History information was reported.On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENITIS (swelling in left armpit lymph node), MYALGIA (I had body ache), NAUSEA (Nausea) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, LYMPHADENITIS (swelling in left armpit lymph node) outcome was unknown and MYALGIA (I had body ache), NAUSEA (Nausea) and CHILLS (Chills) had resolved.Concomitant medications was not provided by the reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Ear pain, Pain in jaw, Vaccination site erythema
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Allergic to sulfa products). On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain). At the time of the report, EAR PAIN (Left ear pain), PAIN IN JAW (Pain at jawline), VACCINATION SITE ERYTHEMA (Redness at left arm) and ARTHRALGIA (Left shoulder pain) outcome was unknown.    The patient who received Moderna Covid-19 booster shot on 03-Dec-2021 was reporting adverse event. The patient reported left shoulder pain, left ear pain, redness at left arm injection site and pain at jawline. No pre-existing condition was reported. allergic to sulfa products.No Concomitant product use was reported.No treatment information was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (was given a 0.5 ml dose as booster dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909, 024M20A and 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On 30-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (was given a 0.5 ml dose as booster dose). On 30-Nov-2021, ACCIDENTAL OVERDOSE (was given a 0.5 ml dose as booster dose) had resolved. Concomitant medication included Diet medicine for an unknown indication.No treatment information was provided by the reporter.Patient was given a 0.5 ml dose as booster dose. Patient was not immunocompromised.Nurse who gave patient booster dose said that it was optional to get full or half dose and let patient choose. Patient was suspicious about this but asked for full dose. Patient stated repeatedly that was no  immunocompromised.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Lymphadenopathy, Myalgia, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), INFLAMMATION (Inflammation), MYALGIA (A sore all over my body, body ache, woke up with body ache) and LYMPHADENOPATHY (Huge lump under my armpit, between my breast and the armpit, like 3 inches, on my breast and armpit, left arm, same as the injection) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination. The patient's past medical history included Vasectomy. On 03-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Dec-2021, the patient experienced PAIN (Pain), INFLAMMATION (Inflammation), MYALGIA (A sore all over my body, body ache, woke up with body ache) and LYMPHADENOPATHY (Huge lump under my armpit, between my breast and the armpit, like 3 inches, on my breast and armpit, left arm, same as the injection). The patient was treated with IBUPROFEN for Pain and Inflammation, at an unspecified dose and frequency. At the time of the report, PAIN (Pain), INFLAMMATION (Inflammation), MYALGIA (A sore all over my body, body ache, woke up with body ache) and LYMPHADENOPATHY (Huge lump under my armpit, between my breast and the armpit, like 3 inches, on my breast and armpit, left arm, same as the injection) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Their arm is  still very sore / arm is ache/ still sore), VACCINATION SITE RASH (Red rash has develop below  were they got  the shot/ the rash is approximately 3inch by 1inch) and VACCINATION SITE ERYTHEMA (Red rash has develop below  were they got  the shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced PAIN IN EXTREMITY (Their arm is  still very sore / arm is ache/ still sore). On 01-Dec-2021, the patient experienced VACCINATION SITE RASH (Red rash has develop below  were they got  the shot/ the rash is approximately 3inch by 1inch) and VACCINATION SITE ERYTHEMA (Red rash has develop below  were they got  the shot). At the time of the report, PAIN IN EXTREMITY (Their arm is  still very sore / arm is ache/ still sore), VACCINATION SITE RASH (Red rash has develop below  were they got  the shot/ the rash is approximately 3inch by 1inch) and VACCINATION SITE ERYTHEMA (Red rash has develop below  were they got  the shot) had not resolved. No concomitant medications provided.No treatment medications provided., patient tried to move the arm a lot thinking it would help and was still sore, she put some ice.This case was linked to MOD-2021-403373 (Patient Link).
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Patient Too Young for Vaccine Administered.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low-
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Confusional state, Dizziness, Fatigue
Clinical narrative: 48 hrs * Cold Chills * Stomach Spasms * Nausea  * Dizziness * Loss of balance  * Confusion * Fatigue * Muscle & headaches  * Palpitations * Sore injection site
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Muscle spasms, Myalgia, Nausea
Clinical narrative: 48 hrs * Cold Chills * Stomach Spasms * Nausea  * Dizziness * Loss of balance  * Confusion * Fatigue * Muscle & headaches  * Palpitations * Sore injection site
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: 48 hrs * Cold Chills * Stomach Spasms * Nausea  * Dizziness * Loss of balance  * Confusion * Fatigue * Muscle & headaches  * Palpitations * Sore injection site
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Lymphadenopathy
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Lymph Node Swelling-Medium
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Antineutrophil cytoplasmic antibody, Antinuclear antibody, Full blood count, Metabolic function test, Thyroid function test
Clinical narrative: On 11/01/21- I had sudden onset hives involving my neck and face. I have never had hives or allergic reaction to anything. Went to Urgent Care, completed round of steroids, pepcid, zyrtec. No relief. Hives reappear in different locations daily. Followed up with PCP and Allergist. Medication dosage increased. Continue to have daily hives despite any pharmaceutical measure.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Tryptase, Urticaria
Clinical narrative: On 11/01/21- I had sudden onset hives involving my neck and face. I have never had hives or allergic reaction to anything. Went to Urgent Care, completed round of steroids, pepcid, zyrtec. No relief. Hives reappear in different locations daily. Followed up with PCP and Allergist. Medication dosage increased. Continue to have daily hives despite any pharmaceutical measure.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Joint swelling, Lethargy, Rash
Clinical narrative: Systemic: Allergic: Rash Generalized-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: swelling of joints-Mild
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Started my period 7 days early (had never happened in my life).  It was thick and dark brown and black.  Then when the period was supposed to start, I had a normal, long (heavy) red period as if I hadn?t already been bleeding got a week.  I?ve been tracking my cycles for over a decade. This is totally unusual.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient stated that itching, red, swollen at injection site and red from vaccine site down to elbow area. As of Saturday, she said swelling was improving. Recommended patient contact health care worker from nursing home to monitor.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Breath sounds, Chest discomfort, Computerised tomogram, Computerised tomogram thorax, Dysphonia
Clinical narrative: I had a scratchy throat when I went to get my covid booster on 12/2/21 but I had no other symptoms. The following day, 12/3/21 I had rapid progression of sore throat and hoarseness. Late 12/3/21, I developed significant noisy breathing and difficulty breathing/chest tightness. I went to the emergency room and was given steroids, which helped my symptoms. It is unclear if this is related to the vaccine and having some underlying existing infection, but I have never had an event like this while sick.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Extra dose administered, Infection, Oropharyngeal pain, Throat irritation
Clinical narrative: I had a scratchy throat when I went to get my covid booster on 12/2/21 but I had no other symptoms. The following day, 12/3/21 I had rapid progression of sore throat and hoarseness. Late 12/3/21, I developed significant noisy breathing and difficulty breathing/chest tightness. I went to the emergency room and was given steroids, which helped my symptoms. It is unclear if this is related to the vaccine and having some underlying existing infection, but I have never had an event like this while sick.